EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H24FN3O4 |
| Net Charge | 0 |
| Average Mass | 401.438 |
| Monoisotopic Mass | 401.17508 |
| SMILES | [H][C@@]12CCCN[C@]1([H])CN(c1c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c1OC)C2 |
| InChI | InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1 |
| InChIKey | FABPRXSRWADJSP-MEDUHNTESA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | antibacterial agent A substance (or active part thereof) that kills or slows the growth of bacteria. anti-obesity agent Any substance which is used to reduce or control weight. antiviral agent A substance that destroys or inhibits replication of viruses. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. antibacterial drug A drug used to treat or prevent bacterial infections. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. |
| Applications: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. anti-asthmatic agent Any compound that has anti-asthmatic effects. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. anti-ulcer drug One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. antirheumatic drug A drug used to treat rheumatoid arthritis. vasodilator agent A drug used to cause dilation of the blood vessels. anti-inflammatory agent Any compound that has anti-inflammatory effects. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. hypoglycemic agent A drug which lowers the blood glucose level. vasoconstrictor agent Drug used to cause constriction of the blood vessels. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. anticonvulsant A drug used to prevent seizures or reduce their severity. antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. antiparkinson drug A drug used in the treatment of Parkinson's disease. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. antibacterial drug A drug used to treat or prevent bacterial infections. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. laxative An agent that produces a soft formed stool, and relaxes and loosens the bowels, typically used over a protracted period, to relieve constipation. Compare with cathartic, which is a substance that accelerates defecation. A substances can be both a laxative and a cathartic. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. hyperglycemic agent A drug which increases the blood glucose level. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| moxifloxacin (CHEBI:63611) has role analgesic (CHEBI:35480) |
| moxifloxacin (CHEBI:63611) has role anti-anaemic agent (CHEBI:75835) |
| moxifloxacin (CHEBI:63611) has role anti-asthmatic agent (CHEBI:65023) |
| moxifloxacin (CHEBI:63611) has role anti-HIV agent (CHEBI:64946) |
| moxifloxacin (CHEBI:63611) has role anti-inflammatory agent (CHEBI:67079) |
| moxifloxacin (CHEBI:63611) has role anti-obesity agent (CHEBI:74518) |
| moxifloxacin (CHEBI:63611) has role anti-ulcer drug (CHEBI:49201) |
| moxifloxacin (CHEBI:63611) has role antibacterial agent (CHEBI:33282) |
| moxifloxacin (CHEBI:63611) has role antibacterial drug (CHEBI:36047) |
| moxifloxacin (CHEBI:63611) has role anticonvulsant (CHEBI:35623) |
| moxifloxacin (CHEBI:63611) has role antiemetic (CHEBI:50919) |
| moxifloxacin (CHEBI:63611) has role antihypertensive agent (CHEBI:35674) |
| moxifloxacin (CHEBI:63611) has role antiinfective agent (CHEBI:35441) |
| moxifloxacin (CHEBI:63611) has role antimalarial (CHEBI:38068) |
| moxifloxacin (CHEBI:63611) has role antimicrobial agent (CHEBI:33281) |
| moxifloxacin (CHEBI:63611) has role antineoplastic agent (CHEBI:35610) |
| moxifloxacin (CHEBI:63611) has role antiparkinson drug (CHEBI:48407) |
| moxifloxacin (CHEBI:63611) has role antipsychotic agent (CHEBI:35476) |
| moxifloxacin (CHEBI:63611) has role antirheumatic drug (CHEBI:35842) |
| moxifloxacin (CHEBI:63611) has role antitubercular agent (CHEBI:33231) |
| moxifloxacin (CHEBI:63611) has role antiviral agent (CHEBI:22587) |
| moxifloxacin (CHEBI:63611) has role cardiovascular drug (CHEBI:35554) |
| moxifloxacin (CHEBI:63611) has role hyperglycemic agent (CHEBI:76916) |
| moxifloxacin (CHEBI:63611) has role hypoglycemic agent (CHEBI:35526) |
| moxifloxacin (CHEBI:63611) has role laxative (CHEBI:50503) |
| moxifloxacin (CHEBI:63611) has role ophthalmology drug (CHEBI:66981) |
| moxifloxacin (CHEBI:63611) has role vasoconstrictor agent (CHEBI:50514) |
| moxifloxacin (CHEBI:63611) has role vasodilator agent (CHEBI:35620) |
| moxifloxacin (CHEBI:63611) is a aromatic ether (CHEBI:35618) |
| moxifloxacin (CHEBI:63611) is a cyclopropanes (CHEBI:51454) |
| moxifloxacin (CHEBI:63611) is a fluoroquinolone antibiotic (CHEBI:87211) |
| moxifloxacin (CHEBI:63611) is a pyrrolidinopiperidine (CHEBI:63697) |
| moxifloxacin (CHEBI:63611) is a quinolinemonocarboxylic acid (CHEBI:26512) |
| moxifloxacin (CHEBI:63611) is a quinolone (CHEBI:23765) |
| moxifloxacin (CHEBI:63611) is a quinolone antibiotic (CHEBI:86324) |
| moxifloxacin (CHEBI:63611) is conjugate base of moxifloxacinium(1+) (CHEBI:63699) |
| Incoming Relation(s) |
| moxifloxacinium(1+) (CHEBI:63699) is conjugate acid of moxifloxacin (CHEBI:63611) |
| IUPAC Name |
|---|
| 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| INNs | Source |
|---|---|
| moxifloxacin | ChemIDplus |
| moxifloxacino | WHO MedNet |
| Synonyms | Source |
|---|---|
| 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid | ChemIDplus |
| Avelox iv | ChEMBL |
| Moxifloxacin | KEGG COMPOUND |
| Zimoxin | ChEMBL |
| Brand Name | Source |
|---|---|
| Avelox i.v. | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Reaxys:8365827 | Reaxys |
| CAS:151096-09-2 | ChemIDplus |
| CAS:151096-09-2 | KEGG COMPOUND |
| Citations |
|---|